VRNA logo

Verona Pharma plc (VRNA) EBITDA

Annual EBITDA:

-$138.53M-$87.37M(-170.77%)
December 31, 2024

Summary

  • As of today, VRNA annual EBITDA is -$138.53 million, with the most recent change of -$87.37 million (-170.77%) on December 31, 2024.
  • During the last 3 years, VRNA annual EBITDA has fallen by -$83.91 million (-153.63%).
  • VRNA annual EBITDA is now -1154308.33% below its all-time high of -$12.00 thousand, reached on December 31, 2005.

Performance

1-Year Change

-170.77%

3-Year Change

-153.63%

5-Year Change

-246.5%

15-Year Change

-309.91%

VRNA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

12.77%
VRNA annual EBITDA is higher than 12.77% of companies in Healthcare sector

Range

All-Time High

-$12.00K
VRNA annual EBITDA is currently >-9900.00% below its historical high of -$12.00 thousand

3-Year Low

-$138.53M
VRNA annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
VRNA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
VRNA next annual earnings announcement has not yet been scheduled

OtherVRNAincome statement metrics

Annual Revenue

$42.30M
VRNA annual revenue is $42.30 million

Annual Net Income

-$173.49M
VRNA annual net profit is -$173.49 million

Annual EBIT

-$139.59M
VRNA annual earnings before interest & taxes is -$139.59 million

Annual EPS

-$2.13
VRNA annual earnings per share is -$2.13

Quarterly EBITDA:

$13.76M+$23.82M(+236.76%)
June 1, 2025

Summary

  • As of today, VRNA quarterly EBITDA is $13.76 million, with the most recent change of +$23.82 million (+236.76%) on June 1, 2025.
  • Over the past year, VRNA quarterly EBITDA has increased by +$81.99 million (+120.17%).
  • VRNA quarterly EBITDA is now at all-time high.

Performance

3-Month Change

+236.76%

1-Year Change

+120.17%

3-Year Change

+168.23%

5-Year Change

+226.76%

VRNA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

81.56%
VRNA quarterly EBITDA is higher than 81.56% of companies in Healthcare sector

Range

All-Time High

$13.76M
VRNA quarterly EBITDA is currently at an all-time high

3-Year Low

-$68.23M
VRNA quarterly EBITDA is currently +120.17% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2025
VRNA previous earnings announcement was published on Jun 1, 2025

Next Quarterly Earnings Report Date

Nov 3, 2025
VRNA next earnings announcement is scheduled for Nov 3, 2025

OtherVRNAincome statement metrics

Quarterly Revenue

$104.36M
VRNA quarterly revenue is $104.36 million

Quarterly Net Income

$12.06M
VRNA quarterly net profit is $12.06 million

Quarterly EBIT

$13.46M
VRNA quarterly earnings before interest & taxes is $13.46 million

Quarterly EPS

$0.13
VRNA quarterly earnings per share is $0.13

TTM EBITDA:

-$55.03M+$81.99M(+59.84%)
June 1, 2025

Summary

  • As of today, VRNA TTM EBITDA is -$55.03 million, with the most recent change of +$81.99 million (+59.84%) on June 1, 2025.
  • Over the past year, VRNA TTM EBITDA has increased by +$75.23 million (+57.75%).
  • VRNA TTM EBITDA is now -4356.54% below its all-time high of -$1.23 million, reached on June 30, 2016.

Performance

3-Month Change

+59.84%

1-Year Change

+57.75%

3-Year Change

+17.34%

5-Year Change

+1.29%

VRNA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

27.84%
VRNA TTM EBITDA is higher than 27.84% of companies in Healthcare sector

Range

All-Time High

-$1.23M
VRNA TTM EBITDA is currently -4356.54% below its historical high of -$1.23 million

3-Year Low

-$155.01M
VRNA TTM EBITDA is currently +64.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2025
VRNA previous earnings announcement was published on Jun 1, 2025

Next Quarterly Earnings Report Date

Nov 3, 2025
VRNA next earnings announcement is scheduled for Nov 3, 2025

OtherVRNAincome statement metrics

TTM Revenue

$222.90M
VRNA TTM revenue is $222.90 million

TTM Net Income

-$81.24M
VRNA TTM net profit is -$81.24 million

TTM EBIT

-$56.15M
VRNA TTM earnings before interest & taxes is -$56.15 million

TTM EPS

-$1.03
VRNA TTM earnings per share is -$1.03

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$138.53M
VRNA annual EBITDA is -$138.53 million

Annual Net Income

-$173.49M
VRNA annual net profit is -$173.49 million

Annual Interest Expense

$0.00
VRNA annual interest expense is $0.00

Annual Income Tax

$6.69M
VRNA annual income tax is $6.69 million

Annual D&A

$1.06M
VRNA annual D&A is $1.06 million

VRNA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-170.8%+120.2%+57.8%
3Y3 Years-153.6%+168.2%+17.3%
5Y5 Years-246.5%+226.8%+1.3%

VRNA EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-170.8%at lowat high+120.2%at high+64.5%
5Y5-Year-246.5%at lowat high+120.2%-23.9%+64.5%
All-TimeAll-Time>-9999.0%at lowat high+120.2%-4356.5%+64.5%

VRNA EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$13.76M(+236.8%)
-$55.03M(+59.8%)
Mar 2025
-
-$10.06M(+43.8%)
-$137.02M(+11.0%)
Dec 2024
-$138.53M(-170.8%)
-$17.91M(+56.1%)
-$153.88M(+0.7%)
Sep 2024
-
-$40.82M(+40.2%)
-$155.01M(-19.0%)
Jun 2024
-
-$68.23M(-153.5%)
-$130.26M(-81.2%)
Mar 2024
-
-$26.92M(-41.3%)
-$71.87M(-7.0%)
Dec 2023
-$51.16M(+24.0%)
-$19.05M(-18.6%)
-$67.19M(-6.4%)
Sep 2023
-
-$16.06M(-63.2%)
-$63.15M(-2.0%)
Jun 2023
-
-$9.84M(+55.8%)
-$61.93M(+14.3%)
Mar 2023
-
-$22.24M(-48.2%)
-$72.26M(+3.4%)
Dec 2022
-$67.29M(-23.2%)
-$15.01M(-1.1%)
-$74.78M(+15.1%)
Sep 2022
-
-$14.84M(+26.4%)
-$88.11M(-32.3%)
Jun 2022
-
-$20.17M(+18.6%)
-$66.58M(+10.9%)
Mar 2022
-
-$24.76M(+12.6%)
-$74.75M(-2.7%)
Dec 2021
-$54.62M(+15.1%)
-$28.34M(-523.7%)
-$72.77M(-63.8%)
Sep 2021
-
$6.69M(+123.6%)
-$44.43M(+38.7%)
Jun 2021
-
-$28.34M(-24.4%)
-$72.44M(-31.8%)
Mar 2021
-
-$22.78M(-6.8%)
-$54.96M(+1.4%)
Dec 2020
-$64.34M(-60.9%)
-
-
Sep 2020
-
-$21.32M(-96.4%)
-$55.75M(-8.4%)
Jun 2020
-
-$10.85M(+24.3%)
-$51.44M(+8.0%)
Mar 2020
-
-$14.33M(-55.1%)
-$55.93M(-8.5%)
Dec 2019
-$39.98M
-$9.24M(+45.7%)
-$51.57M(+0.2%)
Sep 2019
-
-$17.01M(-10.8%)
-$51.68M(-18.9%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$15.35M(-53.9%)
-$43.45M(-21.5%)
Mar 2019
-
-$9.97M(-6.6%)
-$35.76M(-5.4%)
Dec 2018
-$30.36M(+10.2%)
-$9.35M(-6.5%)
-$33.93M(+12.2%)
Sep 2018
-
-$8.78M(-14.7%)
-$38.67M(+4.5%)
Jun 2018
-
-$7.65M(+6.1%)
-$40.49M(-6.0%)
Mar 2018
-
-$8.15M(+42.2%)
-$38.20M(-15.1%)
Dec 2017
-$33.79M(-370.2%)
-$14.09M(-32.9%)
-$33.20M(-56.3%)
Sep 2017
-
-$10.60M(-97.8%)
-$21.23M(-60.4%)
Jun 2017
-
-$5.36M(-70.7%)
-$13.24M(-45.3%)
Mar 2017
-
-$3.14M(-47.9%)
-$9.11M(-52.6%)
Dec 2016
-$7.19M(+45.4%)
-$2.12M(+18.7%)
-$5.97M(-55.2%)
Sep 2016
-
-$2.61M(-111.5%)
-$3.85M(-211.5%)
Jun 2016
-
-$1.23M
-$1.23M
Dec 2015
-$13.17M(-126.2%)
-
-
Dec 2014
-$5.82M(-27.0%)
-
-
Dec 2013
-$4.58M(-11.0%)
-
-
Dec 2012
-$4.13M(-45.8%)
-
-
Dec 2011
-$2.83M(+1.4%)
-
-
Dec 2010
-$2.87M(-12.6%)
-
-
Dec 2009
-$2.55M(-18.9%)
-
-
Dec 2008
-$2.15M(+16.2%)
-
-
Dec 2007
-$2.56M(-95.5%)
-
-
Dec 2006
-$1.31M(>-9900.0%)
-
-
Dec 2005
-$12.00K
-
-

FAQ

  • What is Verona Pharma plc annual EBITDA?
  • What is the all-time high annual EBITDA for Verona Pharma plc?
  • What is Verona Pharma plc annual EBITDA year-on-year change?
  • What is Verona Pharma plc quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Verona Pharma plc?
  • What is Verona Pharma plc quarterly EBITDA year-on-year change?
  • What is Verona Pharma plc TTM EBITDA?
  • What is the all-time high TTM EBITDA for Verona Pharma plc?
  • What is Verona Pharma plc TTM EBITDA year-on-year change?

What is Verona Pharma plc annual EBITDA?

The current annual EBITDA of VRNA is -$138.53M

What is the all-time high annual EBITDA for Verona Pharma plc?

Verona Pharma plc all-time high annual EBITDA is -$12.00K

What is Verona Pharma plc annual EBITDA year-on-year change?

Over the past year, VRNA annual EBITDA has changed by -$87.37M (-170.77%)

What is Verona Pharma plc quarterly EBITDA?

The current quarterly EBITDA of VRNA is $13.76M

What is the all-time high quarterly EBITDA for Verona Pharma plc?

Verona Pharma plc all-time high quarterly EBITDA is $13.76M

What is Verona Pharma plc quarterly EBITDA year-on-year change?

Over the past year, VRNA quarterly EBITDA has changed by +$81.99M (+120.17%)

What is Verona Pharma plc TTM EBITDA?

The current TTM EBITDA of VRNA is -$55.03M

What is the all-time high TTM EBITDA for Verona Pharma plc?

Verona Pharma plc all-time high TTM EBITDA is -$1.23M

What is Verona Pharma plc TTM EBITDA year-on-year change?

Over the past year, VRNA TTM EBITDA has changed by +$75.23M (+57.75%)
On this page